Aurelio Pio Nardozza

1.9k total citations · 1 hit paper
18 papers, 1.4k citations indexed

About

Aurelio Pio Nardozza is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Aurelio Pio Nardozza has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Hematology and 4 papers in Oncology. Recurrent topics in Aurelio Pio Nardozza's work include Protein Tyrosine Phosphatases (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and PARP inhibition in cancer therapy (4 papers). Aurelio Pio Nardozza is often cited by papers focused on Protein Tyrosine Phosphatases (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and PARP inhibition in cancer therapy (4 papers). Aurelio Pio Nardozza collaborates with scholars based in Italy, Netherlands and Germany. Aurelio Pio Nardozza's co-authors include Gianni Cesareni, Luisa Castagnoli, Francesca Sacco, Daniele Peluso, Anita Palma, Elena Santonico, Marta Iannuccelli, Livia Perfetto, Luana Licata and Leonardo Briganti and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Aurelio Pio Nardozza

18 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MINT, the molecular interaction database: 2012 update

2011 792 citations Luana Licata, Leonardo Briganti et al. Nucleic Acids Research profile →

Peers

Countries citing papers authored by Aurelio Pio Nardozza

Since Specialization

Citations

This map shows the geographic impact of Aurelio Pio Nardozza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurelio Pio Nardozza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurelio Pio Nardozza more than expected).

Fields of papers citing papers by Aurelio Pio Nardozza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurelio Pio Nardozza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurelio Pio Nardozza. The network helps show where Aurelio Pio Nardozza may publish in the future.

Co-authorship network of co-authors of Aurelio Pio Nardozza

This figure shows the co-authorship network connecting the top 25 collaborators of Aurelio Pio Nardozza. A scholar is included among the top collaborators of Aurelio Pio Nardozza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurelio Pio Nardozza. Aurelio Pio Nardozza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Synthesis and Macrodomain Binding of Gln‐carba‐ADPr‐peptide 2024 ·ChemBioChem ·(unknown), Aurelio Pio Nardozza, (unknown), Herman S. Overkleeft, Gijsbert A. van der Marel, Andreas G. Ladurner, Dmitri V. Filippov	1
2	Full Treatment-Free Remission Outcome in Patients with Chronic Myeloid Leukemia in Chronic Phase Following One Year of Nilotinib De-Escalation: 96-Week Update of Dante Study 2023 ·Blood ·Alessandra Iurlo, Massimo Breccia, Fabio Stagno, Elisabetta Abruzzese, Fabrizio Pane, Immacolata Attolico, Paolo Sportoletti, Marco Cerrano, Sara Galimberti, Barbara Scappini, Maurizio Miglino, Sergio Siragusa, (unknown), (unknown), Aurelio Pio Nardozza, (unknown), Paola Coco, Giuseppe Saglio, Gianantonio Rosti	5
3	The Economic Burden of Chronic Myeloid Leukemia in Patients with Later Lines: Findings from a Real-World Analysis in Italy 2022 ·Advances in Therapy ·Massimo Breccia, (unknown), Aurelio Pio Nardozza, (unknown), Valentina Perrone, Diego Sangiorgi, Elisa Giacomini, (unknown), Paola Coco, (unknown), Luca Degli Esposti	4
4	Treatment-Free Remission Outcome in Patients with Chronic Myeloid Leukemia in Chronic Phase Following One Year of Nilotinib De-Escalation: 96-Week Update of Dante Study 2022 ·Blood ·Fabio Stagno, Elisabetta Abruzzese, Alessandra Iurlo, Fabrizio Pane, (unknown), Paolo Sportoletti, Patrizia Pregno, Sara Galimberti, Barbara Scappini, Maurizio Miglino, Sergio Siragusa, (unknown), (unknown), Aurelio Pio Nardozza, Paola Coco, Gianantonio Rosti, Giuseppe Saglio, Massimo Breccia	6
5	A Phase II, Single-Arm Study of De-Escalation and Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Treated with Nilotinib in First-Line Therapy Followed By a Second Attempt after Nilotinib and Asciminib Combination: Dante Study 2022 ·Blood ·Gianantonio Rosti, Giuseppe Saglio, Fabio Stagno, (unknown), Aurelio Pio Nardozza, Paola Coco, Massimo Breccia, Alessandra Iurlo	2
6	Real-World Analysis of the Therapeutic Management and Disease Burden in Chronic Myeloid Leukemia Patients with Later Lines in Italy 2022 ·Journal of Clinical Medicine ·Massimo Breccia, (unknown), Aurelio Pio Nardozza, (unknown), Valentina Perrone, Diego Sangiorgi, Elisa Giacomini, (unknown), Paola Coco, (unknown), Luca Degli Esposti	11
7	A Poly-ADP-Ribose Trigger Releases the Auto-Inhibition of a Chromatin Remodeling Oncogene 2017 ·Molecular Cell ·Hari Singh, Aurelio Pio Nardozza, Ingvar R. Möller, (unknown), Hans A. V. Kistemaker, Markus Hassler, (unknown), Charlotte Blessing, Sebastian Eustermann, (unknown), Sébastien Huet, Felix Mueller‐Planitz, Dmitri V. Filippov, Gyula Timinszky, Kasper D. Rand, Andreas G. Ladurner	65
8	Synthesis and Macrodomain Binding of Mono‐ADP‐Ribosylated Peptides 2016 ·Angewandte Chemie ·Hans A. V. Kistemaker, Aurelio Pio Nardozza, Herman S. Overkleeft, Gijs A. van der Marel, Andreas G. Ladurner, Dmitri V. Filippov	37
9	Synthesis and Macrodomain Binding of Mono‐ADP‐Ribosylated Peptides 2016 ·Angewandte Chemie International Edition ·Hans A. V. Kistemaker, Aurelio Pio Nardozza, Herman S. Overkleeft, D. van der Marel, Andreas G. Ladurner, Dmitri V. Filippov	51
10	Metformin Protects Skeletal Muscle from Cardiotoxin Induced Degeneration 2014 ·PLoS ONE ·Francesca Langone, Stefano Cannata, Claudia Fuoco, Daniele Lettieri‐Barbato, Stefano Testa, Aurelio Pio Nardozza, Maria Rosa Ciriolo, Luisa Castagnoli, Cesare Gargioli, Gianni Cesareni	46
11	Counteracting Effects Operating on Src Homology 2 Domain-containing Protein-tyrosine Phosphatase 2 (SHP2) Function Drive Selection of the Recurrent Y62D and Y63C Substitutions in Noonan Syndrome* 2012 ·Journal of Biological Chemistry ·Simone Martinelli, Aurelio Pio Nardozza, (unknown), (unknown), Paola Torreri, Gianfranco Bocchinfuso, Elisabetta Flex, Serenella Venanzi, Antonio Palleschi, Bruce D. Gelb, Gianni Cesareni, Lorenzo Stella, Luisa Castagnoli, Marco Tartaglia	26
12	HuPho: the human phosphatase portal 2012 ·FEBS Journal ·(unknown), Francesca Sacco, Alberto Calderone, Livia Perfetto, Marta Iannuccelli, Simona Panni, Elena Santonico, Anita Palma, Aurelio Pio Nardozza, Luisa Castagnoli, Gianni Cesareni	51
13	Reactive Oxygen Species and Epidermal Growth Factor Are Antagonistic Cues Controlling SHP-2 Dimerization 2012 ·Molecular and Cellular Biology ·Aurelio Pio Nardozza, Melania D’Orazio, Riccardo Trapannone, Salvatore Corallino, Giuseppe Filomeni, Marco Tartaglia, Andrea Battistoni, Gianni Cesareni, Luisa Castagnoli	9
14	MINT, the molecular interaction database: 2012 update breakdown → 2011 ·Nucleic Acids Research ·Luana Licata, Leonardo Briganti, Daniele Peluso, Livia Perfetto, Marta Iannuccelli, Eugenia Galeota, Francesca Sacco, Anita Palma, Aurelio Pio Nardozza, Elena Santonico, Luisa Castagnoli, Gianni Cesareni	792
15	The 4G10, pY20 and p-TYR-100 antibody specificity: profiling by peptide microarrays 2011 ·New Biotechnology ·Michele Tinti, Aurelio Pio Nardozza, Emanuela Ferrari, Francesca Sacco, Salvatore Corallino, Luisa Castagnoli, Gianni Cesareni	44
16	Identification of New Substrates of the Protein-tyrosine Phosphatase PTP1B by Bayesian Integration of Proteome Evidence 2010 ·Journal of Biological Chemistry ·Emanuela Ferrari, Michele Tinti, Stefano Costa, Salvatore Corallino, Aurelio Pio Nardozza, Andrew Chatr‐aryamontri, Arnaud Céol, Gianni Cesareni, Luisa Castagnoli	38
17	Tumor Suppressor Density-enhanced Phosphatase-1 (DEP-1) Inhibits the RAS Pathway by Direct Dephosphorylation of ERK1/2 Kinases 2009 ·Journal of Biological Chemistry ·Francesca Sacco, Michele Tinti, Anita Palma, Emanuela Ferrari, Aurelio Pio Nardozza, Rob Hooft van Huijsduijnen, Takamune Takahashi, Luisa Castagnoli, Gianni Cesareni	62
18	VirusMINT: a viral protein interaction database 2008 ·Nucleic Acids Research ·Andrew Chatr‐aryamontri, Arnaud Céol, Daniele Peluso, Aurelio Pio Nardozza, Simona Panni, Francesca Sacco, Michele Tinti, Alex Smolyar, Luisa Castagnoli, Marc Vidal, (unknown), Gianni Cesareni	155

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact